UNS 0.00% 0.5¢ unilife corporation

Response to Biodel's Complaint, page-23

  1. 296 Posts.
    Not sure if this has been posted before or not. I can't remember reading it unless it was ages ago.
    Definitely worth a read in my opinion.
    It is a well thought out agreement and seems to have all bases covered. Very interested to see the results of this dispute. I hope it can be realised amicably and launch the drug/device on market. Both UNIS and BIODEL need a win right now.

    http://www.sec.gov/Archives/edgar/data/1322505/000114544313002284/d30729_ex10-26.htm
 
watchlist Created with Sketch. Add UNS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.